Plasma Copeptin and Chronic Kidney Disease Risk in 3 European Cohorts From the General Population

JCI insight- United States

doi 10.1172/jci.insight.121479

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Publisher

American Society for Clinical Investigation

Related search

Plasma Copeptin, Kidney Disease, and Risk for Cardiovascular Morbidity and Mortality in Two Cohorts of Type 2 Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2018English

Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism: Pooled Analysis of Five Prospective General Population Cohorts

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Simplified End Stage Renal Failure Risk Prediction Model for the Low-Risk General Population With Chronic Kidney Disease

PLoS ONE
Multidisciplinary
2019English

Prevalence and Burden of Chronic Kidney Disease Among the General Population and High-Risk Groups in Africa: A Systematic Review

BMJ Open
Medicine
2018English

Framing and Managing Cardiovascular Risk in Chronic Kidney Disease: From Native to Transplanted Kidney

Continuing Cardiology Education
2017English

Determinants of Statural Growth in European Children With Chronic Kidney Disease: Findings From the Cardiovascular Comorbidity in Children With Chronic Kidney Disease (4C) Study

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2019English

Prevalence and Risk Factors of Chronic Kidney Disease and Diabetic Kidney Disease in a Central Chinese Urban Population: A Cross-Sectional Survey

BMC Nephrology
Nephrology
2020English

Chronic Kidney Disease and the Risk of Heart Failure in Men

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2011English

Growth in Children With Chronic Kidney Disease: A Report From the Chronic Kidney Disease in Children Study

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy